Orange Book product · Brand (NDA)
SUPPRELIN LA
HISTRELIN ACETATE
Brand (NDA)NDA 022058RX ENDO OPERATIONS
At a glance
May 03, 2007
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 03, 2007
19 yr 5 mo ago
Patent 8062652 expires
Listed method-of-use patent (U-1197) expiration.
Jun 16, 2026
3 d ago
Today
Pharmaceutical detail
Active ingredient
HISTRELIN ACETATE
Strength
50MG
Dosage form
IMPLANT
Route
SUBCUTANEOUS
TE code
Not listed
Application
NDA 022058
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8062652 | Jun 16, 2026 | 3 d ago | U-1197 |
